George Papakostas, MD
Enriched profileDirector, Treatment-Resistant Depression Studies, Depression Clinical and Research Program, Massachusetts General Hospital; Associate Professor of Psychiatry, Harvard Medical School · Massachusetts General Hospital
George Papakostas is Director, Treatment-Resistant Depression Studies, Depression Clinical and Research Program, Massachusetts General Hospital; Associate Professor of Psychiatry, Harvard Medical School at Massachusetts General Hospital. OpenAlex indexes 1,166 publications with 16,342 citations (h-index 67); ClinicalTrials.gov lists 7 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Psychiatry profiles in the findmyKOL directory.
Data verified 17 Aug 2026
Overview
Updated 16 Oct 2026
George Papakostas, MD, is Director, Treatment-Resistant Depression Studies, Depression Clinical and Research Program, Massachusetts General Hospital. The public record shows 1,166 publications with 16,342 citations (h-index 67), centered on Treatment of Major Depression, Tryptophan and brain disorders, Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 8 companies, 2 NIH-funded awards (2004–2012).
- Top research focus: Treatment of Major Depression
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 8 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 212.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- Trial of Low Field Magnetic Stimulation Augmentation of Antidepressant Therapy in Treatment-Resistant Depression
Sponsor: Massachusetts General Hospital
- Exploring a Potential Blood Test to Diagnose Major Depressive Disorder
Sponsor: Massachusetts General Hospital
Industry payments
Updated 16 Oct 2026
8 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202531 payments$20,331openpaymentsdata.cms.gov ↗
- Boehringer Ingelheim International GmbHProgram year20252 payments
- Boehringer Ingelheim International GmbHProgram year20248 payments$19,347openpaymentsdata.cms.gov ↗
NIH funding
Updated 16 Oct 2026
2 NIH research awards on record, funded 2004–2012 per NIH RePORTER. The latest:
- 1/2-Ziprasidone Augmentation of SSRIs for Treatment-Resistant Depression (TRD)
Massachusetts General Hospital
FY2012$359,618R01MH081240 - 1/2-Ziprasidone Augmentation of SSRIs for Treatment-Resistant Depression (TRD)
Massachusetts General Hospital
FY2011$359,618R01MH081240 - 1/2-Ziprasidone Augmentation of SSRIs for Treatment-Resistant Depression (TRD)
Massachusetts General Hospital
FY2010$363,250R01MH081240
Congress activity
Updated 16 Oct 2026
1 congress contribution (2020) across ENDO per OpenAlex. The most recent:
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Efficacy of Esketamine Augmentation in Major Depressive Disorder
The Journal of Clinical Psychiatry
2020
Most-cited works
by citation count (OpenAlex)Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/george-papakostas-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
mgh-ctni.org/leadership/george-i-papakostas-m-d
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mgh-ctni.org ↗ - Apple Podcasts
podcasts.apple.com/us/podcast/treatment-resistant-depression/id347054176
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
New York University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗ - Diplomate
American Board of Psychiatry and Neurology (Psychiatry)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗
Editorial & leadership roles
journal and society appointments- Field Editor for Psychopharmacology
The World Journal of Biological Psychiatry
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →advances.massgeneral.org ↗ - Editorial Board Member
Psychiatry Research
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →advances.massgeneral.org ↗
Awards & honors
honors on the public record- Recipient of multiple national and international research awards
including from the American College of Neuropsychopharmacology, American Psychiatric Association, World Federation of Societies of Biological Psychiatry …
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mgh-ctni.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mgh-ctni.org ↗
Secondary affiliations
appointments beyond the home institution- Scientific Director
Massachusetts General Hospital Clinical Trials Network and Institute (MGH CTNI)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mgh-ctni.org ↗ - Director
Harvard Catalyst course on the Design and Conduct of Clinical Trials in Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mgh-ctni.org ↗
Media & interviews
press, podcasts and appearances- Featured speaker
MGH Psychiatry Academy Podcast episode "Treatment-Resistant Depression"
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ajmc.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
James Januzzi, MD
Massachusetts General Hospital
Maurizio Fava, MD
Massachusetts General Hospital
Steven Greenberg, MD
Massachusetts General Hospital
David Scadden, MD
Massachusetts General Hospital
Charles Nemeroff, MD
Dell Medical School
Maurizio Fava, MD
Massachusetts General Hospital
John Krystal, MD
Yale University
Jeffrey Lieberman, MD
Columbia University College of Physicians and Surgeons